Trends & Articles Entheon Biomedical Corp (OTCMKTS:ENTBF) Inks A Pact With Divergence Neuro Technologies Inc To Develop DMT Biomarkers By Larry Zweig February 25, 2021 Entheon Biomedical Corp (OTCMKTS:ENTBF) signed an agreement with Divergence Neuro Technologies Inc (DNT) for R&D of DMT (N, N-Dimethyltryptamine) biomarkers. They will also engage in the development of a predictive model of bi...
